Citas bibligráficas
Valenzuela, C., (2021). Factores asociados a la resistencia bacteriana en pacientes internos de Medicina C del Hospital Regional del Cusco, 2018 [Universidad Andina del Cusco]. https://hdl.handle.net/20.500.12557/4214
Valenzuela, C., Factores asociados a la resistencia bacteriana en pacientes internos de Medicina C del Hospital Regional del Cusco, 2018 []. PE: Universidad Andina del Cusco; 2021. https://hdl.handle.net/20.500.12557/4214
@phdthesis{renati/956454,
title = "Factores asociados a la resistencia bacteriana en pacientes internos de Medicina C del Hospital Regional del Cusco, 2018",
author = "Valenzuela Huamán, César Joe",
publisher = "Universidad Andina del Cusco",
year = "2021"
}
The goal of the present research was to determine the relationship between treatment factors and bacteria, associated with bacterial resistance described in the medical records of internal patients in the medicine C department of the Regional Hospital of Cusco between the years of 2014 to 2018, where a study was conducted from a transversal analytical quantitative approach, descriptive scope, retrospective control case, data were taken from the medical records where the results showed: age is a risk factor for the appearance of bacterial resistance and sex is not a risk factor, The bacteria with the highest bacterial resistance were: Mycobacterium tuberculosis with 43.2%, Pseudomonas with 29.7%, Klebsiella pneumoninae with 16.2 y Gram- negative bacteria 10.8%; the antibiotics which had a higher bacterial resistance were the ones belonging to the scheme I in 43.2%, ceftriaxone in 24.3%, azithromycin in 16.2% and ceftriaxone plus azithromycin in 16.2% and the pathologies with highest bacterial resistance were 56.8% for pneumonia and 43.2% for tuberculosis, so it is concluded that there is a direct relationship between the treatment factor and the bacteria that showed resistance, in the tuberculosis cases it was observed that the bacteria were resistance to scheme I (Isoniazide, Rifanpicin, Etambutol, Pyrazinamide); of Pseudomonas resistant to cefriaxone, azithromycin and ceftriaxone plus azithromycin, Klebsiella pneumoninae resistant to cefriaxone and ceftriaxone plus azithromycin, Gram- negative bacteria resistant to cefriaxone, azithromycin and ceftriaxone plus azithromycin.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons